We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial.
- Authors
Bonds, D E; Lasser, N; Qi, L; Brzyski, R; Caan, B; Heiss, G; Limacher, M C; Liu, J H; Mason, E; Oberman, A; O'Sullivan, M J; Phillips, L S; Prineas, R J; Tinker, L
- Abstract
Recent clinical trials have found that the combination of conjugated equine oestrogen (CEO) and medroxyprogesterone has a protective effect on the incidence of type 2 diabetes. To determine the effect of CEO alone on the incidence of diabetes mellitus in postmenopausal women, we analysed the results of the Women's Health Initiative oestrogen-alone trial.
- Publication
Diabetologia, 2006, Vol 49, Issue 3, p459
- ISSN
0012-186X
- Publication type
Journal Article
- DOI
10.1007/s00125-005-0096-0